0.29
price down icon8.98%   -0.0286
after-market After Hours: .30 0.01 +3.45%
loading
Enzo Biochem Inc stock is traded at $0.29, with a volume of 559.05K. It is down -8.98% in the last 24 hours and down -37.63% over the past month. Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
See More
Previous Close:
$0.3186
Open:
$0.34
24h Volume:
559.05K
Relative Volume:
3.37
Market Cap:
$15.20M
Revenue:
$30.31M
Net Income/Loss:
$-22.84M
P/E Ratio:
-0.6444
EPS:
-0.45
Net Cash Flow:
$-22.61M
1W Performance:
-32.76%
1M Performance:
-37.63%
6M Performance:
-74.56%
1Y Performance:
-77.17%
1-Day Range:
Value
$0.252
$0.34
1-Week Range:
Value
$0.252
$0.37
52-Week Range:
Value
$0.252
$1.30

Enzo Biochem Inc Stock (ENZ) Company Profile

Name
Name
Enzo Biochem Inc
Name
Phone
(516) 755-5500
Name
Address
60 EXECUTIVE BLVD, FARMINGDALE, NY
Name
Employee
136
Name
Twitter
@enzo_biochem
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
ENZ's Discussions on Twitter

Compare ENZ with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
ENZ
Enzo Biochem Inc
0.29 15.20M 30.31M -22.84M -22.61M -0.45
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
437.91 165.21B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
181.77 130.05B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
393.73 31.91B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
103.00 29.38B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.73 27.28B 15.41B 1.37B 2.11B 7.50

Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-18-11 Reiterated Rodman & Renshaw Mkt Outperform
Sep-23-09 Initiated Rodman & Renshaw Mkt Outperform
Sep-13-07 Initiated Lazard Capital Buy

Enzo Biochem Inc Stock (ENZ) Latest News

pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem Announces Notification to New York Stock - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily - Bluefield Daily Telegraph

Mar 28, 2025
pulisher
Mar 28, 2025

NYSE Delisting Alert: Enzo Biochem Moving to OTCQXWhat Shareholders Must Know - Stock Titan

Mar 28, 2025
pulisher
Mar 24, 2025

Here’s Why Enzo Biochem (ENZ) Declined in Q4 - Yahoo Finance

Mar 24, 2025
pulisher
Mar 20, 2025

ENZ Stock Down Following Q2 Earnings, Revenues Decline Y/Y - Nasdaq

Mar 20, 2025
pulisher
Mar 18, 2025

Enzo Biochem Inc (ENZ) Reports Q2 Fiscal 2025 Revenue of $7.3 Mi - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Enzo Biochem: Fiscal Q2 Earnings Snapshot - The Pioneer

Mar 18, 2025
pulisher
Mar 17, 2025

Enzo Biochem Reports Decline in Quarterly Revenues - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

Enzo Biochem Inc. ($0.01 Par Value) (ENZ) reports earnings - Quartz

Mar 17, 2025
pulisher
Mar 17, 2025

Enzo Biochem Stages Comeback: Q2 Shows 18% Growth, Key Segment Returns to Profit - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Enzo Biochem: Fiscal Q2 Earnings Snapshot -March 17, 2025 at 04:30 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

ENZO BIOCHEM INC SEC 10-Q Report - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Protein Stability Analysis Market Future Business - openPR

Mar 17, 2025
pulisher
Mar 15, 2025

Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 15, 2025
pulisher
Mar 09, 2025

Enzo Biochem, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Feb 27, 2025

Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 27, 2025
pulisher
Feb 24, 2025

Protein Stability Analysis Market Generated Opportunities, - openPR

Feb 24, 2025
pulisher
Feb 19, 2025

Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World

Feb 19, 2025
pulisher
Feb 13, 2025

Enzo Biochem, Inc.'s (NYSE:ENZ) 28% Share Price Plunge Could Signal Some Risk - Simply Wall St

Feb 13, 2025
pulisher
Feb 12, 2025

Enzo Biochem stock hits 52-week low at $0.51 amid challenges - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024 - MSN

Feb 12, 2025
pulisher
Feb 04, 2025

Neuroscience Antibodies and Assays Market to Grow by USD 2.20 Billion from 2024-2028, Rising Neurological Disorders Boost Growth, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve

Feb 04, 2025
pulisher
Feb 03, 2025

NYAG’s Enforcement of Mandated Cybersecurity Safeguards Sends Expensive Shock Waves through Varying Industries - Law.com

Feb 03, 2025
pulisher
Feb 03, 2025

StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ) - Defense World

Feb 03, 2025
pulisher
Jan 27, 2025

Enzo Biochem stock hits 52-week low at $0.63 amid market challenges - Investing.com Canada

Jan 27, 2025

Enzo Biochem Inc Stock (ENZ) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$133.87
price down icon 3.49%
diagnostics_research DGX
$164.18
price down icon 3.78%
diagnostics_research LH
$225.00
price down icon 3.62%
diagnostics_research WAT
$324.92
price down icon 5.85%
diagnostics_research MTD
$1,022.66
price down icon 6.63%
diagnostics_research IQV
$154.73
price down icon 7.73%
Cap:     |  Volume (24h):